EU-”People” Research Training Program in Biotech and Bioethics aim to use IC2 non-invasive imaging of beta-cells mass in studies of induced chemeric immuno tolerence in animal moels of diabetes.
Preliminary data with affinity crosslinking and flow cytometry indicate that proteins of the SNARE-cascade regulating the insulin excretion from beta-cells could be associated with the IC2 specific targeted epitope.
A large international research consortium aim in 2009 to send a proposal to National Institute of Health in USA for funding exploring IC2 ability for clinical medical imaging by immunoPET and immunoPAT.
“Diabetes Studies Review”” May issue 2008, highlight some novel noninvasive imaging approaches with.
A grant from JDRF now unable DNA cloning of IC2. The project runs for two years and was initatied in September 2008.
A consortium consisting of University of Copenhagen, MilleGen in Toulouse and Stanford University collaborate on the DNA clone IC2 and create fusion-proteins for optical in vivo imaging.